Skip to content

Clinical study on the efficacy and safety of ozonated assisted CRRT therapy in patients with sepsis

Clinical study on the efficacy and safety of ozonated assisted CRRT therapy in patients with sepsis

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100051249
Enrollment
Unknown
Registered
2021-09-16
Start date
2021-10-01
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

Group 1:Physiological saline CRRT adjuvant therapy
Group 2:Ozonated Water CRRT adjuvant therapy

Sponsors

Shanghai Oriental Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 80 years, male or female; 2. The diagnostic criteria for sepsis in the new 2016 SSC guidelines were: infection-induced organ dysfunction, increased SOFA score (Table 2-1) by >= 2 points at baseline, and SOFA baseline of 0 points for patients without underlying organ dysfunction; the diagnostic criteria for septic (septic) shock were: on the basis of a definite diagnosis of sepsis, with persistent hypotension, and on the basis of adequate blood volume supplementation, vasopressors were still required to maintain mean arterial pressure >= 65 mmHg and serum lactate level > 2 mmol/L (18 mg/dL). 3. Signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Massive blood loss, acute bleeding, anemia (Hb= 20mg/day; 11. The investigators assess that the subjects are unable or unwilling to comply with the requirements of the research protocol. 12. Acute alcoholism. 13. Severe water and electrolyte disturbances; 14. Hemochromatosis, patients receiving copper or iron therapy; 15. Allergy to anticoagulants (sodium citrate).

Design outcomes

Primary

MeasureTime frame
C-reactive protein;TNF-a;

Countries

China

Contacts

Public ContactLiao Lijun

Shanghai Oriental Hospital

liao@pan-support.com+86 13817428913

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026